DekaBank Deutsche Girozentrale Sells 32,562 Shares of Danaher Corporation $DHR

DekaBank Deutsche Girozentrale lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 4.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 678,074 shares of the conglomerate’s stock after selling 32,562 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Danaher were worth $135,574,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Hills Bank & Trust Co boosted its position in Danaher by 0.3% during the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock valued at $3,693,000 after purchasing an additional 53 shares in the last quarter. Worth Financial Advisory Group LLC boosted its position in Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after purchasing an additional 53 shares in the last quarter. Sageworth Trust Co boosted its position in Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock valued at $493,000 after purchasing an additional 54 shares in the last quarter. 1834 Investment Advisors Co. boosted its position in Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 54 shares in the last quarter. Finally, Bruce G. Allen Investments LLC boosted its position in Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after purchasing an additional 54 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.5%

Danaher stock opened at $208.06 on Tuesday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $274.21. The company has a market capitalization of $148.98 billion, a price-to-earnings ratio of 44.27, a price-to-earnings-growth ratio of 2.98 and a beta of 0.77. The stock has a 50-day moving average price of $201.76 and a 200 day moving average price of $197.42.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 earnings per share. The company’s revenue was up 3.4% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is 27.23%.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.20% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on DHR shares. Wells Fargo & Company dropped their price objective on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 23rd. Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Bank of America lowered their price target on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Royal Bank Of Canada set a $241.00 price target on Danaher in a report on Tuesday, September 2nd. Finally, UBS Group lowered their price target on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $245.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.